BioLineRx (BLRX) EPS (Basic) Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.92% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 43.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45.92% |
| Sep 30, 2025 | -27.61% |
| Jun 30, 2025 | -60.57% |
| Mar 31, 2025 | -38.91% |
| Dec 31, 2024 | 26.65% |
| Sep 30, 2024 | 34.78% |
| Jun 30, 2024 | -123.49% |
| Mar 31, 2024 | -74.43% |
| Dec 31, 2023 | 37.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 38.67% |
| Mar 31, 2023 | 37.00% |
| Dec 31, 2022 | 50.70% |
| Sep 30, 2022 | 30.66% |
| Jun 30, 2022 | -37.00% |
| Mar 31, 2022 | 41.52% |
| Dec 31, 2021 | 43.01% |
| Sep 30, 2021 | 44.97% |
| Jun 30, 2021 | 30.06% |
| Mar 31, 2021 | 30.66% |
| Dec 31, 2020 | 17.02% |
| Sep 30, 2020 | 34.14% |
| Jun 30, 2020 | 15.66% |
| Mar 31, 2020 | 20.63% |
| Dec 31, 2019 | 5.01% |
| Sep 30, 2019 | 27.89% |
| Jun 30, 2019 | 37.00% |
| Mar 31, 2019 | 5.90% |
| Dec 31, 2018 | 13.79% |
| Sep 30, 2018 | -193.90% |
| Jun 30, 2018 | 17.79% |
| Mar 31, 2018 | 15.94% |
| Dec 31, 2017 | -743.35% |
| Jun 30, 2017 | 25.31% |
| Mar 31, 2017 | -115.44% |
| Dec 31, 2016 | -51.83% |
| Sep 30, 2016 | -58.74% |
| Jun 30, 2016 | -51.83% |
| Mar 31, 2016 | -44.22% |